Furthermore, AFP-targeted CAR-T cells exhibited significant anti-HCC activity in both in vivo and in vitro studies (12), while high CD133 expression in HCC was associated with poor prognosis (13). This evidence concerns the gene AFP and hepatocellular carcinoma.